Three five-part hematology analyzers were featured at the company’s stand in Hall 03 covering the range of laboratory needs from the manual BC-5300, to the mid-line automated BC-5380
The Procter & Gamble company is voluntarily recalling three lots of its Vicks Sinex nasal spray in three countries, the US, Germany and the UK. The company said
The US House of Representatives has passed the Chemical and Water Security Act of 2009 (HR 2868) by 230 to 193 votes. Over 21 Democrats joined all 172
NicOx has received a filing communication from the FDA stating that the New Drug Application (NDA) for Naproxcinod is accepted for filing. NicOx submitted the NDA on September
Dow has published a new Company Databook: The Elements of Success. This inaugural edition provides comprehensive insight into Dow as a specialty chemicals and advanced materials company. Andrew
InterMune has modified the on-going Phase 2b study conducted by Roche of ITMN-191 (RG7227) combined with standard of care (SOC) Pegasys (peginterferon alfa-2a) and Copegus (ribavirin) in HCV
UK-based Reaxa has received research and development grant from the Northwest Regional Development Agency (NWDA). The fund for R&D amounts to £146K (E164K). The grant is expected to
BARDA (Biomedical Advanced Research and Development Authority) has awarded a new contract to Bavarian Nordic for the development of a freeze-dried version of its Imvamune smallpox vaccine with
Albireo has completed the Phase 1b study showing a favorable tolerability and safety profile of A3309 in patients with chronic idiopathic constipation. In addition, the data revealed appropriate
Teva UK has entered the G-CSF therapy area, by developing biosimilar medicines. The company has launched its proprietary version of filgrastim,’TevaGrastim’. TevaGrastim is licensed for a number of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.